United Therapeutics Corp. (UTHR)
484.73
+8.37
(+1.76%)
USD |
NASDAQ |
Dec 10, 16:00
484.73
0.00 (0.00%)
After-Hours: 16:18
United Therapeutics Profit Margin (Quarterly): 42.36% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | -6.50% |
| Amgen, Inc. | 33.55% |
| Insmed, Inc. | -260.0% |
| Corcept Therapeutics, Inc. | 9.32% |
| Catalyst Pharmaceuticals, Inc. | 35.57% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.20% |
| Return on Assets | 16.93% |
| Return on Invested Capital | 18.69% |
| Gross Profit Margin (Quarterly) | 87.38% |
| Operating Margin (Quarterly) | 48.69% |
| Return on Net Operating Assets | 66.24% |